Inmed Pharmaceuticals Inc (NQ: INM )
0.3977
-0.0138
(-3.35%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
All News about Inmed Pharmaceuticals Inc
![](https://cdn.benzinga.com/files/images/story/2023/01/06/image47.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-federal-hall.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/01/05/image31_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/01/05/image29.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-pre-market.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/01/04/image22.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/01/04/image27.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2021/05/wall-street-morning.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/12/19/cannabis_shacking_hands_lindsayfox_and_tusumi_by_pixabay.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_24058.jpeg?width=1200&height=800&fit=crop)
Stocks That Hit 52-Week Lows On Friday
December 23, 2022
Via Benzinga
![](https://ml.globenewswire.com/media/8813fbc0-4fc6-42d1-b9be-5355fee305b8/small/inmed-pharmaceuticals-inc-jpg.jpg)
InMed Announces Results of 2022 Annual General Meeting
December 15, 2022
Via GlobeNewswire
![](https://ml.globenewswire.com/media/8813fbc0-4fc6-42d1-b9be-5355fee305b8/small/inmed-pharmaceuticals-inc-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/11/22/jeff.jpg?width=1200&height=800&fit=crop)
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Close on $6M Private Placement Funding
November 22, 2022
Via CannabisNewsWire
Topics
Intellectual Property
Exposures
Intellectual Property
![](https://ml.globenewswire.com/media/8813fbc0-4fc6-42d1-b9be-5355fee305b8/small/inmed-pharmaceuticals-inc-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/11/21/image_5.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/18/image13.jpg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/8813fbc0-4fc6-42d1-b9be-5355fee305b8/small/inmed-pharmaceuticals-inc-jpg.jpg)
![](https://ml.globenewswire.com/media/8813fbc0-4fc6-42d1-b9be-5355fee305b8/small/inmed-pharmaceuticals-inc-jpg.jpg)
InMed Provides Update on Management Changes
November 17, 2022
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2022/11/17/image26.jpeg?width=1200&height=800&fit=crop)
![](https://spotlightgrowth.com/wp-content/uploads/2022/11/InMed-Pharmaceuticals-NASDAQ-INM-Research-Grant-Cannabinoid-Neurodegenerative-Diseases-Funding-Spotlight-Growth.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/11/16/image34.jpeg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.